No Detail Found!

Effectiveness of Entecavir or Tenofovir in Eradicating Chronic Hepatitis B Infection in Patients with Superimposed Acute Hepatitis a / E Virus Infection.

Author(s)
Mohammad Humayun Department of Medicine, Khyber Teaching Hospital, Peshawar, Pakistan
Aliena Badshah Department of Medicine, Khyber Teaching Hospital, Peshawar, Pakistan
Iqbal Haider Department of Medicine, Khyber Teaching Hospital, Peshawar, Pakistan
Abstract
Objective: To determine the effectiveness of Entecavir or Tenofovir in eradication of chronic Hepatitis B infection in patients with superimposed acute hepatitis A or E infection. Material and Methods: This simple, non-blinded randomized controlled trial was conducted in Department of Medicine, Khyber Teaching Hospital, Peshawar and the private practice of primary author from February, 2011 to April, 2017.702 chronic Hepatitis B patients of either gender, aged between 14 and 55 were recruited in the study after fulfilling the inclusion criteria. These patients were initially chronic Hepatitis B positive, but were not started on antiviral therapy owing to low viral counts. They subsequently developed acute hepatitis (either Hepatitis A or E).60% of the patients had positive hepatitis E serology, while 40% had positive serology for hepatitis A.These patients were divided into 3 wings: 1. 281 patients were started on Entecavir 0.5mg OD; 2. 281 patients were started on Tenofovir 300mg OD; 3. 140 patients who were willing to wait for spontaneous clearance of the virus were started on liver supplements used as placebo. These patients were followed at every 4 weeks for first 3 months and then every 6 months for the next 3 years. HBsAg clearance by 3rd generation ELISA, and negative HBV PCR at 12 months was taken as End Point of the study. Results were analyzed using SPSS 23 and expressed in percentages.  Results: At the end of 6 months, 39.1% of patients started on either of Entecavir or Tenofovir achieved HBsAg clearance with negative PCR for Hepatitis B virus DNA, while only 3.3% of the placebo group achieved HBsAg negativity with negative PCR. At 12 months of initiation of treatment, 55% of patients started on either of Entecavir or Tenofovir achieved HBsAg clearance with negative PCR, while only 3.3% of the placebo group did. Conclusion: No statistical difference was found between Entecavir and Tenofovir in the management of Acute Hepatitis in Chronic Hepatitis B patients with superimposed acute Hepatitis A / E.Both entecavir and tenofovir were statistically significant as compared to placebo in the management of Acute Hepatitis in Chronic Hepatitis B patients with super-imposed acute Hepatitis A / E
Publication Details
Page(s) 109-114
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 26, Issue: 2, Year: 2018

Request the full text from PASTIC

References
KimKM,EoSJ,GwakGY,ChoiMS,LeeJH,KohKC, 2011.Comparison of the clinical features of hepatitis A between HBsAg-positive and HBsAg-negative patients,Gut and liver 5 500 -05
SagnelliE,CoppolaN,PisaturoM,PisapiaR,OnofrioM,SagnelliC, 2006.Clinical and Virological Improvement of Hepatitis B Virus-Related or Hepatitis C Virus-Related Chronic Hepatitis with Concomitant Hepatitis A Virus Infection,Clinical infectious diseases 42 1536 -43
ZhangX,KeW,XieJ,ZhaoZ,XieD, 2010.Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B,Hepatol Int 4 615 -20
2007.,Korean journal of hepatology 13 495 -502
Pramoolsinsap C., 2000.Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B virus (HBV) carriers and in HBV-or hepatitis C virus-related chronic liver diseases in Thailand,J Viral Hepat 7 11 -12
AhnSH,LeeHW,KimSU,KimJK,PaikYH,LeeKS, 2007.Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea,Eur J Gastroenterol Hepatol 19 923 -26
PolsonJ,LeeWM, 2005.AASLD position paper: the management of acute liver failure,Hepatology 41 1179 -97
1983.,Hepatology 3 528 -31
TassopoulosN,PapaevangeL,RoumeliotouK,KalafatasP,EngleR,GerinJ, 1985.Double infections with hepatitis A and B viruses,Liver International 5 348 -53
DeterdingK,TegtmeyerB,CornbergM,HademJ,PotthoffA,BökerKH, 2006.Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV,Journal of hepatology 45 770 -78
TongMJ,El-FarraNS,GrewMI., 1995.Clinical manifestations of hepatitis A: recent experience in a community teaching hospital,Journal of Infectious Diseases 171 15 -8
KeeffeEB, 1995.Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?,Am J Gastroenterol 90 201 -05
ForbesA,WilliamsR, 1990.Changing epidemiology and clinical aspects of hepatitis A,Br Med Bull 46 303 -18
VentoS,GarofanoT,RenziniC,CainelliF,CasaliF,GhironziG, 1998.Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C,N Engl J Med 338 286 -90
AlmasioPL,AmorosoP. HAV, 2003.infection in chronic liver disease: a rationale for vaccination,Vaccine 21 2238 -41
SherlockS.,PramoolsinsapC,PoovorawanY,HirschP,BusagornN,AttamasirikulK.,Acute, 1999.hepatitis-A super-infection in HBV carriers, or chronic liver disease related to HBV or HCV,Ann Trop Med Parositol 93 745 -51
CooksleyWG, 2000.What did we learn from the Shanghai hepatitis A epidemic?,J Viral Hep 7 1 -3
RomanoM,DiMN,PesceM. HCV, 1995.superinfection in a chronic carrier of HBV,Minerva gastroenterologica e dietologica 41 303 -05
ChuCM,YehCT,LiawYF, 1999.Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis,J Clin Microbiol 37 235 -37
ChuCM,YehCT,SheenIS,LiawYF, 2002.Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV,Gut 51 95 -99
XiaodanZ,WeiminK,HongC,YingZ,YangsuH., 2003.Clinical disease features of sporadic hepatitis A affected by chronic infection of hepatitis B virus,Chin J Coal Ind Med 6 100 -01
XiangmingX,HongC,HongD,YangsuH,WeiminK., 2000.Effect of basis on chronic infection of hepatitis B virus on clinical features of sporadic hepatitis E,Pract Prevent Med 7 247 -49
SainokamiS,AbeK,KumagaiI,MiyasakaA,EndoR,TakikawaY, 2004.Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A,Journal of gastroenterology 39 640 -48
MahtabMA,RahmanS,KhanM,MamunAA,AfrozS., 2008.Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh,Hepatobiliary Pancreat Dis Int 7 161 -64
XiongLS,CuiSF,ZhouJG,XingY, 2004.Detection and analysis of HAV-HEV, HGV infection in patients with viral hepatitis,ZhonghuaGanZang Bing ZaZhi 12 395 -96
HamidSS,AtiqM,ShehzadF,YasmeenA,NissaT,SalamA, 2002.Hepatitis E virus superinfection in patients with chronic liver disease,Hepatology 36 474 -8
KeWM,LiXJ,YuLN,LaiJ,LiXH,GaoZL, 2006.Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China,Journal of gastroenterology 4 347 -51
ZhangGS,FengFM,LiYL,YuanJX,Shang H, 2006.A study of chronic hepatitis B infection superinfected with hepatitis E infection,Chinese journal of hepatology 14 906 -08
KumarM,SharmaBC,SarinSK, 2008.Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease,J Gastroenterol Hepatol 23 883 -7
0

Citations

0

Downloads

65

Views